3D Tissue Models

Pharmacology: Dana-Farber Cancer Institute

Total Score People Score Events Score
7 7 1
Date Event Presentation Speakers
April 6, 2013 AACR Annual Meetings Mutations in Epigenetic Regulators in Cancer Chairperson: Scott A. Armstrong, Memorial Sloan-Kettering Cancer Center, New York, NY Charles W. M. Roberts
Emerging Targets in the Treatment of Lung Cancer Co-Chairpersons: William Pao, Vanderbilt University, Nashville, TN, and Matthew L. Meyerson, Dana-Farber Cancer Institute, Boston, MA Matthew L. Meyerson
Novel Mechanisms of Cancer Genomic Alteration Adam Bass
Clonal Evolution of Cancer Chairperson: Matthew J. Walter, Washington University School of Medicine, St. Louis, MO Catherine J. Wu
PARP Inhibitors in Cancer Therapy Chairperson: Ralph Scully, Beth Israel Deaconess Medical Center, Boston, MA Judy E. Garber
Developing Targeted Therapies in Lung Cancer Alice T. Shaw, Massachusetts General Hospital Cancer Center, Boston, MA Alice T. Shaw
Evaluating Positive and Negative Selection in Cancer Genomes Rameen Beroukhim, Dana-Farber Cancer Institute, Boston, MA Rameen Beroukhim
Impact of Genomics on Clinical Cancer Genetics Judy E. Garber, Dana-Farber Cancer Institute, Boston, MA Judy E. Garber
About Us | Privacy Policy | Site Map | FAQs | Advertise With Us | Community
BiotechScienceNews.com promotes research and ranks life scientists working in the life science spectrum involving biotechnology,
drug discovery, genomics, microbiology, neuroscience, medicine, pharmacology, cell biology, and molecular biology.